Log In
BCIQ
Print this Print this
 

LY2874455

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionFibroblast growth factor (FGF) receptor (FGFR) inhibitor
Molecular Target Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Cancer (unspecified)
Indication DetailsTreat advanced cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today